Strong growth masked by treasury volatility; NIM pressure near-term
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade B
Met credit cost & revenue guidance; opex growth 15% vs 13-14% guided. NIM guidance (5.8% FY27) at risk near-term.
Optimistic
next 1–2 quarters
Optimistic
multi-year
Core operating momentum intact (OPM +290 bps YoY, opex leverage improving) but near-term NIM pressure from FCNR mobilization and excess liquidity drags reported profitability. PAT growth of 202% inflated by treasury variance, not core business. ROA on track ~1% if NIM recovers as guided; key risk is if deposit mix-driven margin compression persists beyond Q3.
₹11923.3 Cr
Revenue · +20% YoY₹1049.2 Cr
Reported PAT · +201.7% YoYExpanding
Margins · vs guidance: MixedDid the claims hold up?
Core PAT crossed INR1,000 crore for second consecutive quarter
METDelivered PAT ₹1,049.2 Cr; core PAT (ex-treasury) approximately ₹1,036 Cr per mgmt
Operating profit up 38.5% YoY, margin expanding
METOPM improved from ~18.5% (prior year Q2) to 21.4% (Q2 FY27), +290 bps YoY
Loan growth 30.1% YoY including FCNR
MISSRevenue growth only 20% YoY despite 30% loan growth; non-loan segments or rates lagging
NIM moderating due to FCNR, liquidity, asset mix; expect recovery to 5.8%
OVERSTATEDNIM under pressure in Q2; FY27 5.8% guidance at risk unless sharp recovery in Q3-Q4
Credit cost improving, 1.38% in Q2 vs 1.53% Q1
MET1.38% is within 1.5%-1.6% guidance; improvement validated
Opex growth 15% YoY
OVERSTATEDOpex INR5,942 Cr, 16% YoY growth per call; exceeds prior 13-14% guidance
ROA on trajectory for ~1% full year
METQ2 annualized ROA ~0.99%, claim credible but tight margin vs 1% target
QoQ PAT marginally down due to treasury income variance
METQoQ PAT -8.6%; treasury income fell from INR181 Cr (Q1) to INR11 Cr (Q2); explains gap
Earnings quality
What changed since the last call
FCNR deposit mobilization scale
New₹34,400 Cr raised (10% of deposits); not flagged in prior guidance. Strategic win but creates 16 bps NIM headwind Q2.
NIM guidance trajectory revised down near-term
DowngradeFY27 5.8% target still held, but Q2 reality shows 32 bps headwinds vs implicit Q1 baseline. Recovery to 5.8% now seen as Q3-Q4 event, not steady-state.
Opex growth expectation raised
Downgrade15% YoY growth in Q2 vs 13-14% prior guidance. Attributed to branch expansion & tech, managed within overall CIR bridge.
Asset quality trajectory remains on track
NeutralGNPA improved 19 bps to 1.32% (from 1.51% Q1). No change to 1.5%-1.6% credit cost guidance. Macro watch remains cautious (El Niño, drought).
Deposit franchise strength validated
UpgradeCASA deposits ₹1.66L Cr growing 19.8% YoY, above loan growth pace. Demonstrates funding stability & optionality for future FCNR-like moves.
ROA trajectory confidence reaffirmed
MaintainedAnnualized Q2 ROA ~0.99%, on path to ~1% FY27 target. Management cites operating leverage, margin expansion, reduced credit costs.
The Q&A
Moderate analyst pushback on NIM, FCNR cost transparency, opex growth, and asset quality in drought areas. Management held firm on guidance trajectory while acknowledging timing headwinds. No evasion on Q2 misses (QoQ PAT, opex guidance) — attributed to temporary factors.
FCNR cost-of-funds impact — Akshay Jain, Autonomous
AnsweredFCNR cost ~6.86% vs ~7.45%-7.50% domestic; 40-60 bps benefit net of hedging. But FCNR lend rates tied to IBU, creating 16 bps NIM headwind on portfolio mix. Offset by 1% benefit on cost of capital & no PSL requirement.
Deposit LDR and growth cadence — Jai Prakash Mundhra, ICICI Securities
PartialDeposits expected to grow ahead of loans. FCNR inflows managed to preserve LDR. Estimate Q3-Q4 normalization at 115%-116% LCR (vs Sept 139% due to excess liquidity parking).
NIM bridge and 55% cost-to-income path — Param Subramanian, Investec
PartialIncremental cost-to-income ratio for H1 is 55%, validating path. Assumes 20% both loan and deposit growth, modest repo hikes (25 bps more priced in), NIM recovery to 5.8%. Managing quarter-to-quarter, but fundamentals support trajectory.
Asset quality & El Niño impact — Param Subramanian, Investec
AnsweredNo pressure yet. Cautious on 2-3 drought-affected states; expect reasonable numbers couple of quarters. Definitely comfortable with 1.5%-1.6% guidance. Watch rural portfolio, but delinquency low.
CASA growth and structuring — Piran Engineer, CITIC Securities
AnsweredCASA averaging ~30% YoY growth, down to 23% this quarter. Not structural decline, just scale normalization. Target: keep CASA in high 40s% of deposits. No plan to sacrifice CASA for fixed deposits.
Corporate banking economics — Piran Engineer, CITIC Securities
AnsweredCorporate cost-to-income ~32%-33%, yield ~9.2%. Retail CIR higher but customer quality strong. Corporate book 76% A/above-rated, zero delinquency 7 years. ROA differential driven by credit cost & speed of decision-making.
Insurance circular (IRDAI) impact — Abhishek Murarka, HSBC
DodgedInsurance commission change in consultation phase; full impact likely FY28+. Estimated impact material but offset by rate hikes (25 bps done, 25 more expected), FCNR benefit (~100 bps), and opex leverage. Not building conservatism, not optimistic.
Treasury income volatility — Multiple (implied in Q&A flow)
PartialQ2 treasury modest (₹11 Cr) vs ₹181 Cr Q1. No expectation of repeating Q1 levels. Focused on core operating momentum, not trading P&L.
Funding cost and FY28 guidance — Akshay Jain, Autonomous
PartialOff-the-cuff: FY28 COF 3-5 bps higher YoY, assuming continued rate hikes & FCNR repricing. Not a formal guidance, but indicates modest headwind.
Guidance
FY27 loan growth 20%+, deposit growth 20%+
HighQ2 validates: loans +30.1% YoY (excl FCNR +22.2%), deposits +25.9% YoY. Trajectory intact.
FY27 revenue growth tracking 20%+ momentum
HighQ2 FY27 +20% YoY. H1 NII +5.7%, fee +24.5%. Organic momentum strong.
FY27 NIM 5.8% (from 5.75% prior)
MediumQ2 under pressure (32 bps headwind). Recovery expected Q3-Q4 as FCNR normalizes, repo stabilizes. Achievable but timing risk.
FY27 cost-to-income targeting 55% by FY28
HighQ2 incremental CIR 55% (H1 70.2% blended). Path validated via 500 bps opex-income differential management.
Operating leverage expansion to 38%+ operating profit growth
HighQ2 opex growth 15% YoY vs income growth 21% YoY. Incremental CIR 55% validates path.
Branch expansion & tech capex supporting 20%+ growth
MediumCapex embedded in opex growth (15% YoY). No separate capex guidance; tech & infra treated as operating.
Risks the call surfaced
NIM compression
MediumFCNR deposits grew to ₹34,400 Cr, creating 16 bps NIM drag. If deposit mix stays skewed toward FCNR/low-cost bulk, NIM recovery to 5.8% delayed or incomplete.
Macro headwinds (asset quality)
MediumManagement flagged El Niño and drought concern for H2. Rural portfolio concentrated in lenders' books; some states showing pressure. If agricultural stress spreads, credit costs could rise above 1.5%-1.6% guidance.
Opex growth acceleration
LowOpex grew 15% YoY vs 13-14% prior guidance. Branch expansion, tech stack, and digital capex higher than modeled. Could constrain 55% CIR target if opex growth doesn't moderate.
Funding cost trajectory
MediumManagement assumes 25 bps repo hike already done, another 25 bps possible by year-end. FCNR deposits assumed to reprice higher as rates rise. If yield pricing (customer-facing rates) lags liability cost increases, NIM margin erodes further.
Regulatory risk (insurance commission)
LowIRDAI issued consultation paper on insurance commission caps & structure. Full impact expected FY28+. Could reduce insurance fee income materially; timing and scope uncertain.
Management
Score 8/10. Clear, granular disclosure on NIM bridge (32 bps breakdown by factor), FCNR cost structure, and forward CIR path. Transparent on guidance gaps (opex vs prior, NIM timing). Some evasion on IRDAI impact scale and treasury normalization. Delivered H1 revenue +18% YoY, meeting 20%+ loan/deposit growth targets. Opex growth at 15% exceeds 13-14% guidance; asset quality improved; credit cost beat guidance. Track record credible.
1 · Q3/Q4 FY27
NIM recovery as FCNR deposits normalize, excess liquidity deploys, repo rates stabilize
2 · FY28
Cost-to-income ratio trending to 55% target via opex control + income leverage
3 · H2 FY27
Insurance regulatory circular impact (IRDAI commission change) implementation & mitigation
ROA on track ~1% if NIM recovers as guided; key risk is if deposit mix-driven margin compression persists beyond Q3.
Core Growth Solid; Treasury Collapse Hides a Simpler Profit Story
Reported PAT jumped 202% YoY to ₹1,049 crore, but core profit (excluding treasury income) grew only ~20%, in line with revenue. Management reiterated full-year guidance rather than raising it — the call explains why.
₹1,049 Cr
+202% YoY
~₹1,036 Cr
+~20% YoY
₹170 Cr drop
Q1 ₹181 Cr → Q2 ₹11 Cr
+20% YoY
₹11,923 Cr delivered
Where the 202% PAT growth actually came from
On the headline, IDFC First Bank looks like it had a blowout quarter. Reported PAT rocketed 202% YoY. But that headline hides a much more pedestrian story underneath. Core profit — the money the bank actually made from operations — grew only ~20% YoY, exactly in step with revenue growth. The gap between +202% and +20% is almost entirely due to treasury income volatility. Q1 had ₹181 crore in treasury gains; Q2 fell to just ₹11 crore. That ₹170 crore swing explains the -8.6% QoQ PAT decline despite a solid quarter operationally.
Core PAT crossed ₹1,000 crore for the second consecutive quarter.
That statement is the real one. Core profit has stabilised around ₹1,000–1,050 crore per quarter — respectable for a ₹3.5L crore-asset bank, but not headline-grabbing. The market understands this distinction, which is why the stock hasn't celebrated the result.
Management claims vs. what holds up
Loan growth 30.1% YoY (ex-FCNR +22.2%)
Delivered. Loan book ₹3.47L Cr. But revenue only +20% YoY, suggesting non-loan segments or pricing lagging.
Supported (partially)
Operating profit +38.5% YoY, OPM expanding to 21.4%
Delivered: 21.4% vs 18.5% prior-year Q2, +290 bps YoY. Operating leverage real despite NIM headwinds.
Supported
NIM moderating due to FCNR & liquidity; FY27 5.8% guidance intact
NIM under 32 bps pressure Q2. FY27 5.8% contingent on sharp recovery Q3-Q4. Timing risk material.
Overstated
Credit cost 1.38%, within 1.5%-1.6% guidance
Delivered. GNPA improved 19 bps to 1.32%. Asset quality trending positive.
Supported
Opex growth 13-14% (prior guidance)
Actual: 15% YoY. Branch expansion & tech cited. Exceeds prior guide.
Contradicted
ROA ~1% full-year trajectory on track
Q2 annualized ROA ~0.99%. On track but tight vs 1% target.
Supported (tight)
What changed on this call vs. prior quarter
The bull-bear ledger
Core loan & deposit growth (30% / 26% YoY) validates franchise strength
Operating margin expansion to 21.4% (+290 bps YoY) proves real opex leverage
Asset quality improving (GNPA -19 bps to 1.32%); credit cost beat guidance
ROA trajectory ~1% on track; CIR to 55% by FY28 credible (H1 incremental 55%)
Reported PAT +202% inflated by treasury volatility; core growth only ~20%
NIM pressure (32 bps Q2, 16 bps FCNR) makes FY27 5.8% target timing-dependent
Opex growth 15% YoY exceeds prior 13–14% guidance; higher than modeled
Excess liquidity (LCR 125% vs 115% regulatory minimum) parked as low-yield assets
Macro (El Niño drought) and regulatory (IRDAI insurance commission) risks create H2 friction
Risks, ranked by severity for a holder
NIM recovery fails; FCNR mix / repo cycle worsens
HighFY27 5.8% NIM guidance anchors full-year profitability. Q2 showed 32 bps headwind. If FCNR doesn't normalize, excess liquidity isn't deployed, or repo hikes persist, NIM stays compressed and guidance misses. Single biggest near-term risk.
Asset quality deteriorates from El Niño / drought stress
MediumManagement flagged drought concern but stated no pressure yet. Rural portfolio material. If agricultural stress spreads (Maharashtra, Karnataka), credit costs could exceed 1.5–1.6% guidance. Contingency ₹515 Cr may prove insufficient.
Opex growth persists at 15% instead of decelerating
MediumBranch & tech capex discretionary. If 15% opex growth continues, 55% CIR target by FY28 becomes harder. Operating leverage assumption (income +20%, opex +13–14%) would need to hold.
Funding cost inflation outpaces yield repricing
MediumMgmt assumes 25 bps repo hike done, another 25 bps possible by year-end. FCNR reprices higher. If customer rates lag liability costs, NIM compression persists beyond FCNR normalization.
IRDAI insurance commission change reduces fee income materially
LowConsultation paper issued; full impact FY28+. Mgmt confident offsets (rate hikes, FCNR benefit, opex leverage) mitigate, but scope uncertain. Could dent fee income if not offset.
The market's read — where the stock actually stands
The stock closed at ₹73.38 on Oct 29, down 27.1% from its all-time high of ₹100.7. That drawdown is substantial, but the market hasn't panicked — volume is normal, the stock sits just below its 20-, 50-, and 200-day SMAs (₹77.29, ₹82.04, ₹77.03), and RSI at 33.2 is neutral. The street's positioning tells the story: FII holdings are 36.1% (down 0.42pp, a light trim), while DII holdings are 24.37% (up 1.63pp, adding on dips). Promoter ownership remains zero.
This pattern—FII trim, DII add, stock down 27% but not panicked—suggests the market is skeptical of the reported +202% PAT headline but credits the core story (20% revenue growth, 290 bps OPM expansion, 1% ROA trajectory) as credible over time. The drawdown has attracted domestic institutions, who see value post-weakness. The risk from here: NIM pressure persists longer than expected, forcing management to guide down on FY27 or FY28 targets. That would likely trigger a further 5–10% de-rating.
The debate
The honest read: This is a steady quarter, not a step-change. Core profit grew ~20% YoY (in line with revenue); reported profit inflated by treasury swing. Everything hinges on NIM recovery—if FCNR balances normalize and repo rates stabilize, 5.8% is plausible and stock re-rates higher in H2-FY28. If NIM stays compressed, profit growth disappoints and downside risk is 10–15%. Management's tone is confident but cautious—no victory laps on guidance.
1 · Q3 FY27 — NIM recovery trajectory
Is NIM heading back toward 5.8% as FCNR deposits stabilize and excess liquidity deploys? Or is 32 bps of pressure becoming sticky? This is the linchpin for full-year profitability.
2 · Opex growth moderation
Can the bank keep opex growth to 13–14% from Q3 onward, or does 15% persist? If it persists, 55% CIR by FY28 gets harder and operating leverage assumptions shift.
3 · Asset quality (rural / drought areas)
Watch Q3-Q4 credit costs and GNPA trends for deterioration in drought-affected states (Maharashtra, Karnataka, others). Provisions spike would mask operational profitability.
IDFC First Bank is in steady execution mode: franchise growth, operating leverage, ROA improvement are real. But reported profit in Q2 leaned heavily on treasury swing (₹170 Cr QoQ drop). Near-term profitability hinges entirely on NIM recovery—if FCNR normalizes and excess liquidity deploys in Q3-Q4, the margin story holds and stock re-rates. If NIM stays compressed, the stock faces 10–15% further downside.
The single metric to track from here: Q3 NIM. If it's moving back toward 5.8% (currently 5.58%), the bull case holds and patience with the stock pays. If it's stuck below 5.4%, prepare for guidance revise and reset expectations lower.
IDFC First Bank Q2FY27: consol PAT ₹1,049 Cr, +3x YoY off weak base, -9% QoQ
PAT +201.7% YoY · revenue +20% · margins compressing · beat vs street
₹11,923.29 Cr
+20% YoY
₹1,049.17 Cr
+201.7% YoY
7.37%
+4.4pp YoY
₹1.22
IDFC First Bank's consolidated net profit came in at ₹1,049 Cr for Q2 FY27 (standalone ₹1,045 Cr), up ~202% year-on-year from a depressed ₹348 Cr in Q2 FY26, but down 8.6% sequentially from Q1 FY27's record ₹1,148 Cr (standalone -2.8%, from ₹1,075 Cr). Interest earned (revenue) grew a more modest 20.0% YoY and 7.9% QoQ to ₹11,923 Cr consolidated. The headline YoY jump is a base effect, not fresh acceleration: Q2 FY26's profit was itself depressed by elevated provisioning against the bank's microfinance (JLG) book, so the comparison flatters an underlying business that is normalising rather than re-accelerating. Standalone PAT of ₹1,045 Cr did beat the ₹900–950 Cr band we flagged pre-result, by roughly 10-16%; a web search for a separate published Q2 consensus PAT figure turned up nothing beyond our own pre-result expectation range, so that band is the best available Street anchor.
Q2 FY-2027 vs prior quarters
Margins cooled from Q1's peak: operating profit margin fell to 17.9% of total income from 23.8% in Q1 (versus 18.9% a year ago, so YoY is roughly flat), and net profit margin eased to 7.4% from 8.6% QoQ. The squeeze sits mainly on costs rather than credit: standalone operating expenses grew 15.9% YoY, outrunning management's own 13-14% FY27 opex guidance from the Q1 call. Credit quality continued to improve — standalone gross/net NPAs fell to 1.32%/0.40% from 1.51%/0.44% QoQ and 1.86%/0.52% YoY, with provisions down 21.7% YoY to ₹1,137 Cr and running at an annualised pace inside the 150-160bps credit-cost guidance. Annualised ROA eased to 0.93% from 1.05% in Q1, trailing the ~1% full-year ROA target management flagged after Q1's 'kissing distance' quarter; NIM, guided to ~5.8% for FY27 (from 5.75%, and last disclosed at 5.96% in Q1), is not broken out in this filing and could not be confirmed for Q2.
The stock went into the print at ₹72.3, down 15.3% over the past month of trading.
For context: this is the second-highest quarterly PAT of the last 6 quarters; revenue is at a 6-quarter high.
What the summary numbers don't show
Basic EPS ₹1.22 consolidated (₹1.21 standalone) vs ₹1.33 in Q1 and ₹0.35 a year ago
FY27 NIM 5.8% (up from 5.75%), credit cost 150-160 bps (down from 170-180), opex 13-14% growth. Full-year ROA target ~1% (upgraded from Q4 'kissing distance').
— This quarter: met
The quarter's corporate developments support the growth side of the story: the bank's Oct 5 provisional update showed loans up 20.4% YoY and deposits up 17% YoY, squarely within the 20-21%/17-18% growth ranges flagged in our pre-result preview, helped by $3.57B of NRI deposits mobilised via the FCNR(B) window in early September. The board also approved a fresh 98-lakh ESOP grant on Oct 21 and confirmed Shyamal Malhotra's appointment to senior management on Sep 22. No standalone management press release or commentary was available at filing time to cross-check against the Street's framing of this print.
W1
NIM trajectory toward the ~5.8% FY27 guidance (from 5.75%; last disclosed at 5.96% in Q1) — not broken out this quarter, needs confirmation on the Oct 24 call
W2
Opex growth (15.9% YoY standalone) vs the 13-14% FY27 guidance — whether cost growth converges in H2
W3
Annualised ROA (0.93% this quarter vs 1.05% in Q1) against management's ~1% full-year ROA target
Both standalone and consolidated statements present (consolidated adds IDFC FIRST Bharat, the MFI subsidiary); all figures converted from source ₹ lakhs to ₹ crore (÷100); 'Exceptional Items' row is nil in both current and comparison periods so no adjusted-growth carve-out applies; NIM% is not disclosed anywhere in this results statement.
Sustaining the Earnings Surge—Can Growth and Margins Hold?
IDFC First Bank opens FY27 with its highest quarterly profit ever (₹1,075 Cr in Q1). Now comes the test: after a stellar start, does the bank sustain 20%+ loan growth, protect NIMs near 6%, and keep deposit mobility balanced? Provisional Q2 numbers show loans and deposits both tracking hard—the final print will reveal whether profitability momentum is entrenched or a one-quarter spike.
The Setup: Profitability at Inflection
IDFC First Bank reported its highest quarterly profit ever—₹1,075 Cr standalone (₹1,147.82 Cr consolidated)—in Q1 FY27, a 132–153% jump year-over-year. That was driven by core NII growth, lower credit costs normalizing after prior-year strains, and retail loan momentum. The bank guided for 18–20% loan growth and ~5.75% NIM stability for the full year. Now, with provisional Q2 numbers in hand—loans at 20.4% YoY growth, deposits at 17% YoY—the question is whether that profit trajectory holds or moderates as the year progresses.
~₹900–950 Cr
On-plan pace if credit costs remain normalized; below Q1's ₹1,075 Cr is typical seasonal
~5.75%
Guided; Q1 achieved 5.96%. Slight compression normal as funding mix stabilizes
~20–21%
Provisional Q2: 20.4%. Retail (mortgages, autos, consumer) + MSME driving; IBU FCNR adds to headline
~17–18%
Provisional Q2: 17.0%. Slower than loans; CASA 51.3% improving. ₹34,390 Cr FCNR(B) mobilized to bridge
What Strong vs Weak Looks Like
A strong Q2 print: Standalone PAT stays ≥₹900 Cr; NIM holds ≥5.70%; loan growth sustains 20%+; retail proportion of assets stays near 59%; asset quality metrics (slippages, NPA ratio) stay benign; CASA ratio improves further as the bank runs down expensive deposits. Management reiterates guidance for full-year ~18–20% loan growth and ₹20,000 Cr capital raise announced in July proceeding on track.
A weaker print: PAT misses ₹900 Cr (suggesting higher opex or cost-of-funds pressure); NIM compresses below 5.60%; loan growth falters below 18%; deposits decelerate sharply or CASA ratio rolls back, signaling funding stress; slippages or NPA movements tick upward; management reduces guidance or signals capex delays due to capital constraints.
On Track? The FY27 Trajectory
IDFC First is tracking well against its full-year guide. Q1 profit was a standout—driven by credit-cost normalization post-FY26 strains—and Q2 provisional loans and deposits both show the bank on a ~20% advance growth path. The ₹20,000 Cr capital raise (₹7,500 Cr equity + ₹12,500 Cr debt) approved by the board in July and the $1.1B international bond issuances in August-September signal management confidence in growth. Retail focus (59% of funded assets) and IBU FCNR(B) deployment (₹24,885 Cr extended to date) are strategic levers. The key watch: whether NIM remains stable at 5.75% even as deposit-cost dynamics tighten, and whether credit costs stay normalized or spike in a slowing cycle.
The Street's Read
Since Last Quarter: The Filing Scan
1 · Capital Raising: ₹20,000 Cr Approved (Jul 25)
Board approved enabling permission for ₹7,500 Cr equity raise and ₹12,500 Cr debt issuance—both valid one year. Status: equity component likely for branch expansion / balance-sheet growth; debt issuances proceeding (see below).
2 · International Bond Issuances: $1.1B Mobilized (Aug–Sep)
IFSC Banking Unit priced $500M 3-year Senior Notes (Aug 19), upsized to $600M (Aug 19), then added $350M 5-year tranche (Aug 24)—total $1.1B from debut in international DCM. Signals: low-cost foreign funding; capex confidence; diversified funding base. Positive for margin stability.
3 · FCNR(B) Deposit Mobilization: ₹34,390 Cr (Sep 03 & Oct 05)
Mobilized ~US$3.57B (₹33,975 Cr) from NRI customers via RBI's FCNR(B) swap window; IBU branch extended ₹24,885 Cr (~$2.6B) in forward FCNR(B) loans. Strategic: accesses cheaper foreign-currency funding; lowers overall cost of deposits; supports IBU growth. Positive for liquidity and margin.
4 · Management Changes: Shyamal Malhotra Appointed; Ashish Singh to Exit (Aug–Sep)
Shyamal Malhotra appointed as Senior Management Personnel (Sep 22); Ashish Singh (existing senior mgmt) announced resignation, effective Dec 31 2026. Routine changes; no red flags on continuity.
5 · Earnings Call: Oct 24, 2026 at 6:00 p.m. IST
Board to convene on Oct 24 to approve Q2 FY27 unaudited standalone & consolidated financials. Call will provide full-year FY27 guidance and management color on funding, profitability, and asset-quality outlook.
What to Watch on Result Day
1 · Profitability Momentum: Standalone PAT Q2 vs Q1
Q1 standalone PAT was ₹1,075 Cr. Q2 is typically softer seasonally, but the bar is high. Watch whether it stays ≥₹900 Cr (intact momentum) or slips below (credit costs rising, opex inflation, NIM compression). The profit trajectory is what's gotten Street attention.
2 · NIM & Cost-of-Funds: Can Stability Stick?
Q1 NIM was 5.96%, guidance ~5.75%. Q2 NIM is a live test of whether deposit costs have stabilized after FCNR(B) mobilization and international bond issuances. A NIM below 5.65% would raise margin-compression questions; above 5.75% would validate strategy.
3 · Loan Growth Sustainability & Retail Mix
Provisional Q2 loans at 20.4% YoY; retail at 59% of funded assets. Watch final reported numbers and management's breakdown by segment. Any deceleration below 18% or shift away from retail would challenge the full-year 18–20% guidance.
4 · Asset Quality & Slippages
Credit costs normalized dramatically in Q1 (vs FY26). Q2 will show whether that holds or if slippages are creeping up as the growth cycle extends and macro risks loom (sector stress, rate-cycle concerns). Any NPA/slippage spike would weigh on sentiment.
5 · Full-Year Guidance & Capital-Raise Traction
Mgmt reiterated 18–20% loan growth and ~5.75% NIM in Jul. Will Q2 results keep that live, or signal any reset? Separately, ₹20,000 Cr capital raise approved in Jul—any update on timing/pricing for equity portion? Traction here signals long-term confidence.
IDFC First Bank enters Q2 on the back of its best profit quarter ever—a signal of the retailization and cost-normalization payoff. Provisional Q2 numbers (loans +20.4%, deposits +17%) suggest the run-rate is holding, but final reported figures, NIM stability, and forward guidance will be the real tests. The Street sits Neutral, debating whether current valuations (1.5–1.8× P/ABV) fairly price sustainable 18–20% growth + 5.75% margins or whether Q1's +153% profit jump is unsustainable. Three things matter most: Can PAT stay above ₹900 Cr? Will NIM hold near 5.75%? And does management's capital-raise and FCNR(B) strategy keep funding costs under control? Answer yes to all three, and the upside case (targets ₹100+) becomes credible; miss on profitability or margins, and the downside (₹65–75 range) opens up.